The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s protein assay market report forecasts the protein assay market size to grow to $4.20 Billion by 2027, with a CAGR (compound annual growth rate) of more than 12%.

Learn More On The Protein Assay Market Report 2023 – https://www.thebusinessresearchcompany.com/report/protein-assays-global-market-report

Protein Assay Market Size Forecast
The global protein assay market is expected to grow from $2.22 billion in 2022 to $2.60 billion in 2023 at a compound annual growth rate (CAGR) of 16.99%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global protein assay market size is expected to reach $4.20 billion in 2027 at a CAGR of 12.70%.

North America held the largest protein assay market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Protein Assay Market Driver ­– Rapid Development Of Healthcare Infrastructure
According to a report published in November 2022 by the Organisation for Economic Co-operation and Development (OECD), a France-based intergovernmental organisation aimed at promoting economic progress and global trade, health spending as a percentage of GDP increased from 8.8% in 2019 to 9.7% in 2020 across OECD countries. Preliminary forecasts show that health spending in the 20 OECD countries will increase by around 6% in 2021. As a result, the rapid expansion of healthcare infrastructure is propelling the protein assay market forward.

Request for A Sample Of The Global Protein Assay Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9173&type=smp

Key Protein Assay Market Trend – Technological Advancement
Major players in the protein assay market are focusing on developing new technologies to increase their market position. For example, NanoString Technologies Inc., a biotech company based in the United States that provides discovery and translational research solutions, will launch GeoMx Digital Spatial Profiler (DSP) for next-generation sequencing (NGS) readout in November 2020, enabling multi-analyte analysis for both nCounter® and NGS readout. Users of the GeoMx Cancer Transcriptome Atlas will receive supplementary protein material from these tests ready for NGS readout. These novel protein assays have been tested for multi-plex performance on both formalin-fixed paraffin-embedded and fresh frozen tissue. Users may easily compare the levels of protein expression in our prostate cancer samples to the findings from the GeoMx Cancer Transcriptome Atlas using the GeoMx Protein Assays for NGS Readout. The GeoMx DSP protein readouts utilising NGS are available immediately through the company’s Technology Access Programme.

Protein Assay Market Segment
1) By Product Type: Reagents And Kits, Instruments
2) By Technology Type: Absorbance Based Protein Assays, Colorimetric Protein Assays, Fluorescence Based Protein Assays
3) By End User: Pharmaceutical Industry, Biotechnology Industry, Clinical Laboratories, Hospitals, Academic Research Institutes

Protein Assay Market Major Players and Strategies
Major players in the protein assay market are Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., Lonza Group AG, Abcam PLC, PerkinElmer Inc., BioVision Inc., Cell Signaling Technology Inc., Geno Technology Inc., GE HealthCare, Promega Corporation, Novus Biologicals LLC, F. Hoffmann-La Roche AG, Soltec Ventures (Soltec Bio Science) and Takara Bio Inc.

Abcam PLC, a UK-based developer of diagnostic and therapeutic applications, paid USD 340 million for Biovision Inc. in October 2021. This acquisition would improve Abcam’s internal innovation and expand its size to support the cellular and biochemical assay sectors. Abcam now has access to BioVision’s product line, capabilities, and 70-strong experienced production and development teams as a result of this transaction. Biovision Inc. is a firm established in the United States that produces and sells a wide range of products, including assay kits, antibodies, recombinant proteins, and enzymes.

The Protein Assay Global Market Report 2023 covers regional data on protein assay market size, protein assay market trends and drivers, opportunities, strategies, and protein assay market competitor analysis. The countries covered in the protein assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Protein assay refers to the process of determining how many unique proteins are present in a sample, depending on the situation. Protein isolation and detection is used in many clinical and scientific processes. The protein assay is used to determine the presence of a specific protein or a group of proteins in a sample.

View More Reports Related To The Protein Assay Market –
Protein Expression Global Market Report 2023
Protein Labeling Global Market Report 2023
Protein Inhibitors Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: